MedPath

Comparison of the effect and the durability of exercise therapy on pain, movement control , functional and lower extremity flexibility in men with lumbar movement control dysfunctio

Not Applicable
Recruiting
Conditions
umbar movement control dysfunction.
Registration Number
IRCT20200817048433N1
Lead Sponsor
niversity of Tehran
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
60
Inclusion Criteria

Participants should have chronic nonspecific low back pain with movement control dysfunction.
Being classifiedas medium-risk subgroup (Pain range (6 - 3) on the Visual Analoge Scale)
Men aged 30 to 40 years

Exclusion Criteria

Samples show pathological symptoms, history of fractures, tumors, surgery or joint diseases of the spine, pelvis and lower limbs.
having functional or congenital kyphosis and lordosis (higher than 42 and 52 degrees measured by flexible ruler)
having scoliosis (rotation above 5 degrees by scoliometer)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Movement control. Timepoint: Before, 42 days and 28 days after intervention. Method of measurement: Lumajoki movement control tests to diagnose people with lumbar spine control disorder.;Pain. Timepoint: Before, 42 days and 28 days after intervention. Method of measurement: Visual Analogue Scale.;Hip muscle flexibility. Timepoint: Before, 42 days and 28 days after intervention. Method of measurement: Goniometer, which uses the goniometer method to assess the flexibility of the muscles of the Rectus Femoris, Hamstring, External rotator, and Tensor fasciaelatae on both sides of the body.;Lower extremity function. Timepoint: Before, 42 days and 28 days after intervention. Method of measurement: In the present study, lower extremity function will be measured by five tests: static balance,Y Test, Triple hop for distance, Six-meter timed hop and a questionnaire on lower extremity function (Lower Extremity Functional Scale) will be used.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath